Real-World Analysis Suggests Pediatric-Inspired Regimens Lead to Higher Overall Survival in Adolescent and Young Adult Patients with Newly-Diagnosed Acute Lymphoblastic Leukemia
News
Servier Presents Patient Follow Up Data from the Phase 3 AGILE Study at ASH 2022
Servier Wins Reuters’ 2022 Patient Champion Award
New Data at ASH 2022 Bolster Servier’s Leadership in Hematology Research
Servier Pharmaceuticals Partners with Artists for Humanity
Servier Summer Interns Share Their Experiences
Servier Affirms Commitment to Cancer by Announcing the Opening of a Global R&D Center and Expanded Offices in Boston’s Seaport
Servier Statement on U.S. Supreme Court Overturning Roe v. Wade
Reaching New Heights Through the Climb to Fight Cancer Expedition